Skip to main content

Advertisement

Fig. 3 | EJNMMI Radiopharmacy and Chemistry

Fig. 3

From: Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers

Fig. 3

AA-PET and MRI findings in a case of differential diagnosis between TML and breast cancer brain metastasis. 71 years old female patient previously treated for breast cancer who underwent ceMRI that showed the presence of a left frontal lesion hyperintense at T2 sequences (Panel a) and hypointense at T1 sequences (Panel b). AA-PET/CT with 18F-Dopa showed a low tracer uptake supporting the hypothesis of TML. ceMRI performed three months after therapy administration showed the reduction in both lesion dimension (Panel d) and enhancement (Panel e)

Back to article page